Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | ATP dependent DNA helicase Q5 | 0.0021 | 0.6548 | 0.5907 |
Entamoeba histolytica | recQ family helicase, putative | 0.0021 | 0.6548 | 1 |
Schistosoma mansoni | blooms syndrome DNA helicase | 0.0011 | 0.0249 | 0.0249 |
Echinococcus granulosus | ATP dependent DNA helicase Q5 | 0.0021 | 0.6548 | 0.5907 |
Leishmania major | ATP-dependent DEAD/H DNA helicase recQ, putative | 0.0021 | 0.6548 | 0.5 |
Loa Loa (eye worm) | cytoplasmic intermediate filament protein | 0.0014 | 0.2432 | 0.2239 |
Echinococcus granulosus | bloom syndrome protein | 0.0021 | 0.6548 | 0.5907 |
Brugia malayi | ATP-dependent DNA helicase, RecQ family protein | 0.0021 | 0.6548 | 0.5438 |
Loa Loa (eye worm) | intermediate filament protein | 0.0026 | 1 | 1 |
Plasmodium falciparum | ATP-dependent DNA helicase Q1 | 0.0021 | 0.6548 | 0.5 |
Echinococcus multilocularis | lamin dm0 | 0.0026 | 1 | 1 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.0021 | 0.6548 | 1 |
Schistosoma mansoni | lamin | 0.0026 | 1 | 1 |
Echinococcus multilocularis | lamin | 0.0026 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0.1269 | 0.1046 |
Treponema pallidum | ATP-dependent DNA helicase | 0.0011 | 0.0249 | 0.5 |
Giardia lamblia | Sgs1 DNA helicase, putative | 0.0021 | 0.6548 | 0.5 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0026 | 1 | 1 |
Onchocerca volvulus | 0.0026 | 1 | 0.5 | |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.0021 | 0.6548 | 1 |
Schistosoma mansoni | DNA helicase recq5 | 0.0021 | 0.6548 | 0.6548 |
Trichomonas vaginalis | DNA helicase recq, putative | 0.0021 | 0.6548 | 0.5 |
Onchocerca volvulus | 0.0026 | 1 | 0.5 | |
Trichomonas vaginalis | DNA helicase recq, putative | 0.0021 | 0.6548 | 0.5 |
Loa Loa (eye worm) | ATP-dependent DNA helicase | 0.0021 | 0.6548 | 0.646 |
Echinococcus granulosus | lamin | 0.0026 | 1 | 1 |
Trypanosoma cruzi | ATP-dependent DEAD/H DNA helicase recQ, putative | 0.0021 | 0.6548 | 1 |
Trypanosoma brucei | ATP-dependent DEAD/H DNA helicase recQ, putative | 0.0021 | 0.6548 | 0.5 |
Schistosoma mansoni | intermediate filament proteins | 0.0026 | 1 | 1 |
Loa Loa (eye worm) | RecQ helicase | 0.0021 | 0.6548 | 0.646 |
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0.1269 | 0.1046 |
Brugia malayi | ATP-dependent DNA helicase, RecQ family protein | 0.0021 | 0.6548 | 0.5438 |
Schistosoma mansoni | lamin | 0.0026 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0026 | 1 | 1 |
Plasmodium falciparum | ADP-dependent DNA helicase RecQ | 0.0021 | 0.6548 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.6548 | 0.646 |
Schistosoma mansoni | DNA helicase recq1 | 0.0021 | 0.6548 | 0.6548 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0026 | 1 | 1 |
Echinococcus multilocularis | ATP dependent DNA helicase Q1 | 0.0021 | 0.6548 | 0.5907 |
Loa Loa (eye worm) | hypothetical protein | 0.0011 | 0.0249 | 0.0000000054327 |
Trichomonas vaginalis | DNA helicase recq1, putative | 0.0021 | 0.6548 | 0.5 |
Brugia malayi | Bloom's syndrome protein homolog | 0.0021 | 0.6548 | 0.5438 |
Echinococcus granulosus | lamin dm0 | 0.0026 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0026 | 0.9702 | 0.9694 |
Echinococcus granulosus | intermediate filament protein | 0.0026 | 1 | 1 |
Echinococcus multilocularis | musashi | 0.0026 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0013 | 0.1567 | 0.1351 |
Echinococcus granulosus | ATP dependent DNA helicase Q1 | 0.0021 | 0.6548 | 0.5907 |
Entamoeba histolytica | recQ family DNA helicase | 0.0011 | 0.0249 | 0.0381 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.0011 | 0.0249 | 0.0381 |
Echinococcus multilocularis | bloom syndrome protein | 0.0021 | 0.6548 | 0.5907 |
Plasmodium vivax | ADP-dependent DNA helicase RecQ, putative | 0.0011 | 0.0249 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.